Please ensure Javascript is enabled for purposes of website accessibility China’s TopRidge Pharma to produce Sputnik V vaccine, Russia’s RDIF says | #dating | #elderly | #seniors – Active Lifestyle Media

Follow or share

Active Lifestyle Media

DatingChina’s TopRidge Pharma to produce Sputnik V vaccine, Russia’s RDIF says | #dating | #elderly | #seniors

China’s TopRidge Pharma to produce Sputnik V vaccine, Russia’s RDIF says | #dating | #elderly | #seniors

[ad_1]

MOSCOW (Reuters) – China’s TopRidge Pharma has agreed to produce more than 100 million doses of Russia’s two-shot Sputnik V vaccine against COVID-19, Russia’s RDIF sovereign wealth fund said on Thursday.

The fund, which markets Sputnik V globally, said the two sides planned to cooperate on clinical trials in China and to promote its use there.

TopRidge Pharma will be able to distribute the vaccine in mainland China, Hong Kong, Macau and Taiwan, RDIF said in a statement.

(Reporting by Anton Kolodyazhnyy; writing by Tom Balmforth; editing by Jason Neely)

[ad_2]

Click Here For The Original Source

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Leave a Reply